(Q41599028)

4 October 2017

1 reference

title

HLA and cancer: implications for cancer immunotherapy and vaccination (English)

1 reference

4 October 2017

1 reference

Browning M

1

1 reference

4 October 2017

Dunnion D

series ordinal

2

1 reference

4 October 2017

publication date

1 August 1997

1 reference

International Journal of Immunogenetics

4 October 2017

published in

1 reference

4 October 2017

volume

24

1 reference

4 October 2017

issue

4

1 reference

4 October 2017

page(s)

293-312

1 reference

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Tumor escape from immune response by variation in HLA expression and other mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Mechanisms of loss of HLA class I expression on colorectal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Costimulation of T cells for tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Natural history of HLA expression during tumour development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Dendritic cells hold promise for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Surgace IgM specificity on cells derived from a Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Immunotherapeutic elimination of syngeneic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Cytokines, tumour-cell death and immunogenicity: a question of choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Selective changes in expression of HLA class I polymorphic determinants in human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

The new vaccines: building viruses that elicit antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Reduction of major histocompatibility complex class I antigens on invasive and high-grade transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Loss of HLA class-I alleles, heavy chains and β2-microglobulin in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Peptide-based cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2370.1997.TB00025.X

10.1111/J.1365-2370.1997.TB00025.X

21 January 2018

Identifiers

DOI

1 reference

4 October 2017

1 reference